Document Detail

Generalized linear porokeratosis: A rare entity with excellent response to acitretin.
MedLine Citation:
PMID:  21635825     Owner:  NLM     Status:  In-Data-Review    
Linear porokeratosis is a rare disorder of keratinization that usually presents at birth. We report a 17-year-old male with generalized linear porokeratosis, a very rare variant of porokeratosis, with extensive involvement of the trunk and extremities along with nail and genital involvement. The patient was treated with oral acitretin with excellent clinical response.
Taru Garg; Ramchander; Bincy Varghese; Meenu Barara; Anita Nangia
Related Documents :
22976615 - The prevalence of dsm-iv attention-deficit/hyperactivity disorder: a meta-analytic review.
1945505 - Diagnosis and treatment of cervical radiculopathy and myelopathy.
24005985 - Cardiac reactivity and stimulant use in adolescents with autism spectrum disorders with...
24246605 - Comorbidity between major depression and alcohol use disorder from adolescence to adult...
12356925 - A review of functional status measures for workers with upper extremity disorders.
23550245 - Extrapulmonary tuberculosis - three cases in the spine.
Publication Detail:
Type:  Journal Article     Date:  2011-05-15
Journal Detail:
Title:  Dermatology online journal     Volume:  17     ISSN:  1087-2108     ISO Abbreviation:  Dermatol. Online J.     Publication Date:  2011  
Date Detail:
Created Date:  2011-06-03     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9610776     Medline TA:  Dermatol Online J     Country:  United States    
Other Details:
Languages:  eng     Pagination:  3     Citation Subset:  IM    
Department of Dermatology & STD, Dermatology, Venereology & Leprosy, Lady Hardinge Medical College, New Delhi, India.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Unilateral nevoid telangiectasia syndrome: A case report and review of the literature.
Next Document:  Oral melanosis after tyrosine kinase inhibition with Imatinib for chronic myelogenous leukemia: Repo...